---
title: GlaxoSmithKlineâ€™s Delinkage Model
date: 2018-03-13
start_date: Proposed in 2014
description:  An annual payer license combined with a variety of incentives such as PDPs, tax credits, and research grants to delink sales and R&D costs.
status: Proposed
---
